Delivery Order SPE2DB20D2104-SPE2DB23FV16B

Award Date 9/1/23
Potential Completion Date 9/5/23
Potential Value $2.2K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,454.71, is for the delivery of 4,556,012,556 units of Premarin 0.625 mg tablets. The award is a delivery order under an Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Cencora, Inc., doing business as Amerisourcebergen. This single-award IDC, valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,757.50 firm fixed-price delivery order is for the supply of Premarin 0.3 mg tablets. The award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. (doing business as Amerisourcebergen) and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026....
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,256.44, is for the delivery of Premarin 0.625 mg tablets in quantities of 100. The contract is a firm fixed-price delivery order with a completion date of September 7, 2021. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,572.72, is for the delivery of Premarin 1.25 mg tablets. The award has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does business as Amerisourcebergen. Both entities are...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Premarin 0.3 mg tablets. The $4,456.22 firm fixed-price contract is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a...
This federal contract award, valued at $14,293.55, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Premarin 0.3 mg tablets in quantities of 1,000. The contract is a firm-fixed-price delivery order with a completion date of March 13, 2024. This award is not associated with any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that...
This federal contract award, valued at $7,399.49, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Premarin 0.3 mg tablets in 100-count bottles. The award represents a single delivery order under a larger Indefinite Delivery Contract (IDC) held by the parent company, Cencora, Inc., which is valued at up to $999,999,999.00 and runs through November 2026. This IDC serves as the primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Premarin 0.625 mg tablets. The $6,764.59 Firm Fixed Price contract has an ultimate completion date of April 28, 2022. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. This single-award IDC serves as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,784.91 firm fixed-price delivery order is for the supply of Premarin 0.625 mg tablets, a hormone medication, with a completion date of December 3, 2021. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Premarin 1.25 mg tablets. The contract, valued at $5,759.79, is a Firm Fixed Price Delivery Order with a completion date of June 27, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB23FV16B
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,208.38, is for the delivery of Premarin 0.625 mg tablets. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Cencora, Inc. (doing business as Amerisourcebergen), valued at up to $999,999,999.00 and running through December 2025. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen's extensive supply chain and distribution capabilities make the company a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems.

Generated 2/27/25, 11:37 AM